X4 Pharmaceuticals (XFOR) Interest & Investment Income (2017 - 2025)
X4 Pharmaceuticals (XFOR) posted Interest & Investment Income of $2.0 million for Q4 2025, up 120.31% on a QoQ basis from $901000.0 in Q3 2025, and up 56.67% year-over-year from $1.3 million in Q4 2024.
X4 Pharmaceuticals (XFOR) Interest & Investment Income (2017 - 2025) Analysis & Trends
X4 Pharmaceuticals' Interest & Investment Income history runs 9 years deep, the most recent figure standing at $2.0 million for Q4 2025.
- Quarterly Interest & Investment Income rose 56.67% year-over-year to $2.0 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $4.6 million (down 20.68% YoY) and the FY2025 annual result came in at $4.6 million, down 20.68% from the prior year.
- Interest & Investment Income was $2.0 million for Q4 2025 at X4 Pharmaceuticals, up from $901000.0 in the prior quarter.
- Across five years, Interest & Investment Income topped out at $2.0 million in Q4 2025 and bottomed at $2000.0 in Q1 2021.
- A 5-year average of $757800.0 and a median of $868000.0 in 2023 frame the typical range for Interest & Investment Income.
- Annual changes were most pronounced in 2021 — Interest & Investment Income plunged 99.32% — and 2023, when it surged 27733.33%.
- X4 Pharmaceuticals' Interest & Investment Income stood at $3000.0 in 2021, then surged by 6500.0% to $198000.0 in 2022, then soared by 629.8% to $1.4 million in 2023, then slipped by 12.32% to $1.3 million in 2024, then surged by 56.67% to $2.0 million in 2025.
- Business Quant data shows XFOR's Interest & Investment Income at $2.0 million in Q4 2025, $901000.0 in Q3 2025, and $665000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 27.66 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 114.80 Mn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -65.80 Mn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 48.00 Mn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 19.51 Mn |
| 10 | X4 Pharmaceuticals | 167.90 Mn | -49.15 Mn | 2.20 Mn | 1.99 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.99 Mn |
| Sep 30, 2025 | 901,000.00 |
| Jun 30, 2025 | 665,000.00 |
| Mar 31, 2025 | 1.03 Mn |
| Dec 31, 2024 | 1.27 Mn |
| Sep 30, 2024 | 1.87 Mn |
| Jun 30, 2024 | 1.57 Mn |
| Mar 31, 2024 | 1.07 Mn |
| Dec 31, 2023 | 1.45 Mn |
| Sep 30, 2023 | 1.39 Mn |
| Jun 30, 2023 | 914,000.00 |
| Mar 31, 2023 | 835,000.00 |
| Dec 31, 2022 | 198,000.00 |
| Sep 30, 2022 | 14,000.00 |
| Jun 30, 2022 | 4,000.00 |
| Mar 31, 2022 | 3,000.00 |
| Dec 31, 2021 | 3,000.00 |
| Sep 30, 2021 | 2,000.00 |
| Jun 30, 2021 | 3,000.00 |
| Mar 31, 2021 | 2,000.00 |